Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Ethical Issues and Recommendations in Grateful Patient Fundraising and Philanthropy.

Collins ME, Rum S, Wheeler J, Antman K, Brem H, Carrese J, Glennon M, Kahn J, Ohman EM, Jagsi R, Konrath S, Tovino S, Wright S, Sugarman J; Participants in the Summit on the Ethics of Grateful Patient Fundraising.

Acad Med. 2018 Nov;93(11):1631-1637. doi: 10.1097/ACM.0000000000002365.

2.

Building on #MeToo to Enhance the Learning Environment for US Medical Schools.

Antman K.

JAMA. 2018 May 1;319(17):1759-1760. doi: 10.1001/jama.2018.3812. No abstract available.

PMID:
29610835
3.

Recommendations to Sustain the Academic Mission Ecosystem at U.S. Medical Schools.

Kerschner JE, Hedges JR, Antman K, Abraham E, Colón Negrón E, Jameson JL.

Acad Med. 2018 Jul;93(7):985-989. doi: 10.1097/ACM.0000000000002212.

4.

In Reply to Manion and Khan.

Bharel M, Antman K, Berman H, Dimitri D, Flier J, Flotte T.

Acad Med. 2017 Jun;92(6):725-726. doi: 10.1097/ACM.0000000000001713. No abstract available.

PMID:
28557909
5.

Developing Core Competencies for the Prevention and Management of Prescription Drug Misuse: A Medical Education Collaboration in Massachusetts.

Antman KH, Berman HA, Flotte TR, Flier J, Dimitri DM, Bharel M.

Acad Med. 2016 Oct;91(10):1348-1351.

PMID:
27532868
6.

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC Jr, Bennett JM, Benz EJ Jr, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ Jr, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA.

Mayo Clin Proc. 2015 Aug;90(8):996-1000. doi: 10.1016/j.mayocp.2015.06.001. Epub 2015 Jul 23. No abstract available.

7.

Research in academic medical centers: two threats to sustainable support.

Levine AS, Alpern RJ, Andrews NC, Antman K, Balser JR, Berg JM, Davis PB, Fitz JG, Golden RN, Goldman L, Jameson JL, Lee VS, Polonsky KS, Rappley MD, Reece EA, Rothman PB, Schwinn DA, Shapiro LJ, Spiegel AM.

Sci Transl Med. 2015 May 27;7(289):289fs22. doi: 10.1126/scitranslmed.aac5200.

PMID:
26019216
8.

High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma.

Stiff PJ, Agovi MA, Antman KH, Blaise D, Camitta BM, Cairo MS, Childs RW, Edwards JR, Gale RP, Hale GA, Lazarus HM, Arora M.

Biol Blood Marrow Transplant. 2010 Apr;16(4):525-32. doi: 10.1016/j.bbmt.2009.11.020. Epub 2009 Dec 2.

9.

Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer.

Chabot JA, Tsai WY, Fine RL, Chen C, Kumah CK, Antman KA, Grann VR.

J Clin Oncol. 2010 Apr 20;28(12):2058-63. doi: 10.1200/JCO.2009.22.8429. Epub 2009 Aug 17.

10.

Specific barriers to the conduct of randomized trials.

Duley L, Antman K, Arena J, Avezum A, Blumenthal M, Bosch J, Chrolavicius S, Li T, Ounpuu S, Perez AC, Sleight P, Svard R, Temple R, Tsouderous Y, Yunis C, Yusuf S.

Clin Trials. 2008;5(1):40-8. doi: 10.1177/1740774507087704.

PMID:
18283079
11.

A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.

Murabito JM, Rosenberg CL, Finger D, Kreger BE, Levy D, Splansky GL, Antman K, Hwang SJ.

BMC Med Genet. 2007 Sep 19;8 Suppl 1:S6.

12.

Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference.

Hassan R, Alexander R, Antman K, Boffetta P, Churg A, Coit D, Hausner P, Kennedy R, Kindler H, Metintas M, Mutti L, Onda M, Pass H, Premkumar A, Roggli V, Sterman D, Sugarbaker P, Taub R, Verschraegen C.

Ann Oncol. 2006 Nov;17(11):1615-9. Epub 2006 Apr 6.

PMID:
16600983
13.

Update on malignant mesothelioma.

Antman K, Hassan R, Eisner M, Ries LA, Edwards BK.

Oncology (Williston Park). 2005 Sep;19(10):1301-9; discussion 1309-10, 1313-6.

14.

Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.

Zalupski MM, Rankin C, Ryan JR, Lucas DR, Muler J, Lanier KS, Budd GT, Biermann JS, Meyers FJ, Antman K.

Cancer. 2004 Feb 15;100(4):818-25.

15.

High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.

Talbot SM, Rankin C, Taub RN, Balcerzak SP Jr, Bhoopalam N, Chapman RA, Baker LH, Middleman EL, Antman KH.

Cancer. 2003 Jul 15;98(2):331-6.

16.

Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer.

Rizzo JD, Williams S, Wu JT, Pecora AL, Lazarus HM, Bolwell B, Fields KK, Gale RP, Elfenbein G, Horowitz MM, Antman KH.

Bone Marrow Transplant. 2003 Jul;32(2):151-5.

PMID:
12838279
17.

A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma.

Tiersten AD, Nelsen C, Talbot S, Vahdat L, Fine R, Troxel A, Brafman L, Shriberg L, Antman K, Petrylak DP.

Cancer. 2003 Feb 1;97(3):537-44.

18.

Reducing disparities in breast cancer survival: a Columbia University and Avon Breast Cancer Research and Care Network Symposium.

Antman K, Abraido-Lanza AF, Blum D, Brownfield E, Cicatelli B, Debor MD, Emmons K, Fitzgibbon M, Gapstur SM, Gradishar W, Hiatt RA, Hubbell FA, Joe AK, Klassen AC, Lee NC, Linden HM, McMullin J, Mishra SI, Neuhaus C, Olopade FI, Walas K.

Breast Cancer Res Treat. 2002 Oct;75(3):269-80.

PMID:
12353816
19.

Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.

Vahdat LT, Balmaceda C, Papadopoulos K, Frederick D, Donovan D, Sharpe E, Kaufman E, Savage D, Tiersten A, Nichols G, Haythe J, Troxel A, Antman K, Hesdorffer CS.

Bone Marrow Transplant. 2002 Aug;30(3):149-55.

21.

Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study. Southwest Oncology Group.

Budd GT, Rankin C, Hutchins LF, Wong L, Petruska PJ, Antman K; Southwest Oncology Group.

Invest New Drugs. 2002 Feb;20(1):129-32.

PMID:
12003189
22.

Imatinib mesylate--a new oral targeted therapy.

Savage DG, Antman KH.

N Engl J Med. 2002 Feb 28;346(9):683-93. Review. No abstract available.

PMID:
11870247
23.

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry.

Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy PL Jr, Norton L, Parnes H, Pecora A, Perry MC, Rowlings P, Spitzer G, Horowitz MM.

J Clin Oncol. 2002 Feb 1;20(3):743-50.

PMID:
11821456
24.

Overview of the six available randomized trials of high-dose chemotherapy with blood or marrow transplant in breast cancer.

Antman KH.

J Natl Cancer Inst Monogr. 2001;(30):114-6. No abstract available.

PMID:
11773303
25.

New biology and therapies in soft tissue sarcomas.

Antman KH.

Biomed Pharmacother. 2001 Nov;55(9-10):553-7. Review. No abstract available.

PMID:
11769966
26.

Complementary and alternative medicine: the role of the cancer center.

Antman K, Benson MC, Chabot J, Cobrinik D, Grann VR, Jacobson JS, Joe AK, Katz AE, Kelly K, Neugut AI, Russo D, Tiersten A, Weinstein IB.

J Clin Oncol. 2001 Sep 15;19(18 Suppl):55S-60S. No abstract available.

PMID:
11560974
27.

Protocol for the examination of specimens from patients with tumors of the peritoneum: a basis for checklists.

Scully RE, Antman KH; Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2001 Sep;125(9):1174-6. No abstract available.

PMID:
11520266
28.

Reduction of paclitaxel-induced peripheral neuropathy with glutamine.

Vahdat L, Papadopoulos K, Lange D, Leuin S, Kaufman E, Donovan D, Frederick D, Bagiella E, Tiersten A, Nichols G, Garrett T, Savage D, Antman K, Hesdorffer CS, Balmaceda C.

Clin Cancer Res. 2001 May;7(5):1192-7.

29.
30.

Randomized trials of high dose chemotherapy for breast cancer.

Antman KH.

Biochim Biophys Acta. 2001 Mar 21;1471(3):M89-98. Review.

PMID:
11250065
31.

Designing and funding clinical trials of novel therapies.

Antman K, Lagakos S, Drazen J.

N Engl J Med. 2001 Mar 8;344(10):762-3. No abstract available.

PMID:
11236782
32.
33.

High-dose chemotherapy in breast cancer: the end of the beginning?

Antman KH.

Biol Blood Marrow Transplant. 2000;6(5):469-75. Review. No abstract available.

34.

Decision analysis of tamoxifen for the prevention of invasive breast cancer.

Grann VR, Sundararajan V, Jacobson JS, Whang W, Heitjan DF, Antman KH, Neugut AI.

Cancer J. 2000 May-Jun;6(3):169-78.

PMID:
10882333
35.

Kaposi's sarcoma.

Antman K, Chang Y.

N Engl J Med. 2000 Apr 6;342(14):1027-38. Review. No abstract available.

PMID:
10749966
36.

An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2.

Moslehi R, Russo D, Phelan C, Jack E, Antman K, Narod S.

Clin Genet. 2000 Jan;57(1):70-3.

PMID:
10733239
37.

Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.

Grann VR, Jacobson JS, Whang W, Hershman D, Heitjan DF, Antman KH, Neugut AI.

Cancer J Sci Am. 2000 Jan-Feb;6(1):13-20.

PMID:
10696733
38.
39.

Critique of the high-dose chemotherapy studies in breast cancer: a positive look at the data.

Antman KH.

J Clin Oncol. 1999 Nov;17(11 Suppl):30-4. Review. No abstract available.

PMID:
10630259
40.

A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.

Papadopoulos KP, Balmaceda C, Fetell M, Kaufman E, Vahdat LT, Bruce J, Sisti M, Isaacson S, De LaPaz R, Savage DG, Troxel A, Antman KH, Hesdorffer CS.

J Neurooncol. 1999 Sep;44(2):155-62.

PMID:
10619499
41.

High-dose chemotherapy for breast cancer.

Antman KH, Heitjan DF, Hortobagyi GN.

JAMA. 1999 Nov 10;282(18):1701-3. No abstract available.

PMID:
10568629
42.

Dose-intensive therapy for limited-stage small-cell lung cancer: long-term outcome.

Elias A, Ibrahim J, Skarin AT, Wheeler C, McCauley M, Ayash L, Richardson P, Schnipper L, Antman KH, Frei E 3rd.

J Clin Oncol. 1999 Apr;17(4):1175.

PMID:
10561176
43.

Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.

Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, Pelz CJ, Klein JP, Sobocinski KA, Kennedy MJ, Freytes CO, McCarthy PL Jr, Herzig RH, Stadtmauer EA, Lazarus HM, Pecora AL, Bitran JD, Wolff SN, Gale RP, Armitage JO, Vaughan WP, Spitzer G, Horowitz MM.

JAMA. 1999 Oct 13;282(14):1335-43.

PMID:
10527180
44.

High-dose chemotherapy for breast cancer: evolving data.

Antman K, Tiersten A.

Oncology (Williston Park). 1999 Sep;13(9):1215-9. Review. No abstract available.

45.

Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry.

McCarthy P, Hurd D, Rowlings P, Crump M, Gale R, Lazarus H, Vaughan W, Weinberger B, Wiemann M, Freytes C, Cirenza E, Antman K.

Bone Marrow Transplant. 1999 Aug;24(4):365-8.

46.

International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury.

Shipp MA, Abeloff MD, Antman KH, Carroll G, Hagenbeek A, Loeffler M, Montserrat E, Radford JA, Salles G, Schmitz N, Symann M, Armitage JO, Philip T, Coiffier B.

J Clin Oncol. 1999 Jan;17(1):423-9. Review. No abstract available.

PMID:
10458261
47.

Screening mammography under age 50.

Antman K, Shea S.

JAMA. 1999 Apr 28;281(16):1470-2. No abstract available.

PMID:
10227298
48.

Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2.

Grann VR, Whang W, Jacobson JS, Heitjan DF, Antman KH, Neugut AI.

J Clin Oncol. 1999 Feb;17(2):494-500.

PMID:
10080590
49.

International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury.

Shipp MA, Abeloff MD, Antman KH, Carroll G, Hagenbeek A, Loeffler M, Montserrat E, Radford JA, Salles G, Schmitz N, Symann M, Armitage JO, Coiffier B, Philip T.

Ann Oncol. 1999 Jan;10(1):13-9. Review. No abstract available.

PMID:
10076716
50.

High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.

Papadopoulos KP, Garvin JH, Fetell M, Vahdat LT, Garrett TJ, Savage DG, Balmaceda C, Bruce J, Sisti M, Isaacson S, De LaPaz R, Hawks R, Bagiella E, Antman KH, Hesdorffer CS.

Bone Marrow Transplant. 1998 Oct;22(7):661-7.

Supplemental Content

Loading ...
Support Center